Home Neoplasma 2006 Neoplasma Vol.53, p.444-449, 2006

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.53, p.444-449, 2006

Title: Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals
Author: V., OBRADOVIC ; V., ARTIKO ; M., PETROVIC ; Ž., LAUSEVIC ; M., STOJKOVIC ; N., PETROVIC ; D., SOBIC-SARANOVIC ; M., VLAJKOVIC ; Z., KRIVOKAPIC ;

Abstract: The aim of the study was evaluation of the clinical reliability of the immunoscintigraphy for the detection of metastases and recurrences of colorectal carcinomas using three different radiopharmaceutical substances. With IMACIS 1, the number of true negative findings (TN) was 4/7 and true positive (TP) 3/7, while in one patient, the results of immunoscintigraphy significantly influenced the therapeutical management. With INDIMACIS 19-9, there were 2/8 TN and 6/8 TP. In three patients, immunoscintigraphy results influenced patient further management. With ONCOSCINT in 2 patients findings were TN, in one FN and in one FP. In 3 patients, immunoscintigraphy influenced the management of the patient. Other imaging methods (CT, US, MRI) have advantage in detection of liver metastases, while immunoscintigraphy is more specific for the assessment of reccurences of the abdominal tumors. Thus immunoscintigraphy should be applied in patients with suggested recurrences and inconclusive outcome of routine diagnostic workup.

Keywords: immunoscintigraphy, colorectal carcinoma
Year: 2006, Volume: 53, Issue: Page From: 444, Page To: 449

Price: 14.40 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.